JOIN NOW | Print Page | Contact Us | Sign In
Allergy is Changing New Compliance Hurdles for ENTs Practicing Allergy
Tell a Friend About This EventTell a Friend
Allergy is Changing New Compliance Hurdles for ENTs Practicing Allergy

2/26/2020
When: Wednesday, Feb. 26, 2020
1:00 p.m.-2:00 p.m. (Eastern)
Where: Adobe Connect
United States
Contact: Marcus Dean
(412) 243-5156 x102


Online registration is closed.
« Go to Upcoming Event List  

Although there is a temporary reprieve, new allergy compounding standards are coming soon and compliance with USP <797> is already the law in most states. This webinar will cover the what, when, and how of the new standards. Additionally, two Medicare GBAs have mandated minimum dosing requirements for allergy maintenance injections that already went into effect in June of 2019. As a result, the typical ENT allergy methodology is considered "sub-therapeutic" and "not reasonable or necessary" in 17 States. And most concerning, the new dosing is subject to "post payment data analysis and subsequent medical review audits". Learn if your Practice is affected how to parse the new requirements. 

Educational Objectives:

USP<797>

  • Implementation delay and what we know about the new timeline
  • Step-by-step discussion of the requirements
  • Resources for compliance assistance
  • New Medicare Dosing Requirements
  • Which States are affected
  • Urgency to comply
  • How to evaluate your current dosing
  • Resources for compliance assistance

 

About The Speaker: Heather Prichard

Heather Prichard is co-founder and Director of MedAllergy LLC, which provides ancillary allergy services to Otolaryngology practices. Since 2012, MedAllergy has assisted ENT practices with the transition to an evidence-based allergy methodology, resulting in better patient outcomes, lower practice overhead and enhanced practice revenue. 

ASCENT Office

2400 Ardmore Blvd., Suite 302
Pittsburgh, PA 15221
Phone: 412-243-5156
Fax: 412-243-5160

info@askASCENT.org

Privacy Statement